Robert W. Ashworth
General Counsel bei ATYR PHARMA, INC.
Profil
Robert W.
Ashworth's current job is Vice President-Regulatory Affairs at aTyr Pharma, Inc. Dr. Ashworth's former jobs include Vice President-Global Regulatory Affairs at NPS Pharmaceuticals, Inc., Vice President-Regulatory Affairs at Otsuka Pharmaceutical Development & Commercialization, Inc., Senior Vice President-Regulatory Quality & CMC at OncoSec Medical, Inc., and SVP-Regulatory Officer, Quality & Compliance at Advaxis, Inc. Dr. Ashworth's education includes a doctorate degree from Massachusetts Institute of Technology and an undergraduate degree from St. John's University.
Aktive Positionen von Robert W. Ashworth
| Unternehmen | Position | Beginn |
|---|---|---|
| ATYR PHARMA, INC. | General Counsel | 06.10.2021 |
Ehemalige bekannte Positionen von Robert W. Ashworth
| Unternehmen | Position | Ende |
|---|---|---|
| ONCOSEC MEDICAL INCORPORATED | General Counsel | - |
| AYALA PHARMACEUTICALS, INC. | Compliance Officer | 01.01.2018 |
Otsuka Pharmaceutical Development & Commercialization, Inc.
 Otsuka Pharmaceutical Development & Commercialization, Inc. Pharmaceuticals: MajorHealth Technology Part of Otsuka Holdings Co., Ltd., Otsuka Pharmaceutical Development & Commercialization, Inc. is a healthcare company that was founded in 2007. The company is based in Princeton, NJ. The company is driven by their purpose and defined by their beliefs. | General Counsel | - |
| NPS PHARMACEUTICALS, INC. | General Counsel | - |
Ausbildung von Robert W. Ashworth
| Massachusetts Institute of Technology | Doctorate Degree |
| St. John's University | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| ONCOSEC MEDICAL INCORPORATED | Health Services |
| ATYR PHARMA, INC. | Health Technology |
| Private Unternehmen | 3 |
|---|---|
Advaxis, Inc.
 Advaxis, Inc. Pharmaceuticals: MajorHealth Technology Advaxis, Inc. is a biotechnology company, which engages in the discovery, development and commercialization of cancer immunotherapies. It manages platform technology that utilizes live attenuated Listeria monocytogenes bioengineered to secrete antigen or adjuvant fusion proteins. The firm has four franchises in various stages of clinical and pre-clinical development, namely: HPV-associated cancers, prostate cancer, neoantigen therapy and hotspot mutation therapy. The company was founded on June 5, 1987 and is headquartered in Princeton, NJ. | Health Technology |
NPS Pharmaceuticals, Inc.
 NPS Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology NPS Pharmaceuticals, Inc. developed drugs for bone and mineral disorders. It also developed Natpara for the treatment of adult hypoparathyroidism. The company was founded by Hunter Jackson and Thomas N. Parks on October 22, 1986 and is headquartered in Bedminster, NJ. | Health Technology |
Otsuka Pharmaceutical Development & Commercialization, Inc.
Otsuka Pharmaceutical Development & Commercialization, Inc. Pharmaceuticals: MajorHealth Technology Part of Otsuka Holdings Co., Ltd., Otsuka Pharmaceutical Development & Commercialization, Inc. is a healthcare company that was founded in 2007. The company is based in Princeton, NJ. The company is driven by their purpose and defined by their beliefs. | Health Technology |
